Cancer researchers have a multitude of tools to study tumors. Histological staining uses dyes to make different kinds of ...

Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...

Phase 2 study, led by Dr. Antonio Jimeno at the University of Colorado Anschutz Medical Campus will evaluate NT219 in ...

Reduce your other risk factors. Tobacco and alcohol use are some of the strongest lifestyle risk factors for head and neck cancer. In a recent study, tobacco use increased the risk of developing ...

Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...

Merck & Co.’s Keytruda has become the first immunotherapy approved by the FDA to be used around surgery to treat resectable ...

The KEYNOTE-689 study showed pembrolizumab with standard of care significantly improved outcomes for resectable HNSCC, ...

Smoking, alcohol consumption and betel nut chewing are some of the lifestyle factors that have been linked to head and neck ...

There are a number of things to look out for, but many of them often go ignored, according to leading oncologist Dr Jiri ...

Artificial intelligence (AI) tools such as deep learning-based algorithms can be valuable as previous studies have shown a reduction in contouring time and variation. Furthermore, explainable AI (XAI) ...

Leading oncologist Dr Jiri Kubes has shared some of the most common signs of head and neck cancer in a bid to raise awareness ...

The findings represent an important contribution to understanding whether BMI influences head and neck cancer (HNC) risk after accounting for tobacco use. Within the context of the Mendelian ...